Evidence map›Paper›PMID 31398788›Full record

ArticleMarine drugs2019

Purification, Characterization and Evaluation of Inhibitory Mechanism of ACE Inhibitory Peptides from Pearl Oyster (

Pengru Liu, Xiongdiao Lan, Muhammad Yaseen, Shanguang Wu, Xuezhen Feng, Liqin Zhou, Jianhua Sun, Anping Liao, Dankui Liao, Lixia Sun

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Review
  3. Design and synthesis ofRSC advances · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. A Natural Bioactive Peptide fromInternational journal of molecular sciences · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. A Review of Bioactive Compounds in Oyster Shell and Tissues.Frontiers in bioengineering and biotechnology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Pengru LiuGuangxi Key Laboratory of Petrochemical Resource Processing and Process Intensification Technology, School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China.
Xiongdiao LanGuangxi Key Laboratory for Polysaccharide Materials and Modifications, School of Chemistry and Chemical Engineering, Guangxi University for Nationalities, Nanning 530008, China.
Muhammad YaseenInstitute of Chemical Sciences, University of Peshawar, Khyber Pakhtunkhwa 25120, Pakistan.
Shanguang WuMedical College, Guangxi University of Science and Technology, Liuzhou 545006, China.
Xuezhen FengMedical College, Guangxi University of Science and Technology, Liuzhou 545006, China.
Liqin ZhouGuangxi Key Laboratory of Petrochemical Resource Processing and Process Intensification Technology, School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China.
Jianhua SunGuangxi Key Laboratory of Petrochemical Resource Processing and Process Intensification Technology, School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China.
Anping LiaoGuangxi Key Laboratory for Polysaccharide Materials and Modifications, School of Chemistry and Chemical Engineering, Guangxi University for Nationalities, Nanning 530008, China.
Dankui LiaoGuangxi Key Laboratory of Petrochemical Resource Processing and Process Intensification Technology, School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China. liaodankuigx@163.com.
Lixia SunGuangxi Key Laboratory of Petrochemical Resource Processing and Process Intensification Technology, School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China. binglin0628@163.com.
Guangxi University · CNGuangxi University for Nationalities · CNGuangxi University of Science and Technology · CNUniversity of Peshawar · PK

Funding

National Natural Science Foundation of China 51372043Project of Guangxi Natural Science Foundation 2017GXNSFDA198052
6 · The paper itself

Abstract

Angiotensin-I-converting enzyme (ACE) inhibitory peptides derived from natural products have shown a blood pressure lowering effect with no side effects. In this study, two novel ACE inhibitory peptides (His-Leu-His-Thr, HLHT and Gly-Trp-Ala, GWA) were purified from pearl oyster (

Indexed as

Angiotensin-Converting Enzyme InhibitorsAnimalsAntihypertensive AgentsChromatography, High Pressure LiquidHypertensionMaleMeatMolecular Docking SimulationPeptidesPeptidyl-Dipeptidase APinctadaProtein HydrolysatesRatsRats, Sprague-DawleyUltrafiltrationAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsPeptidesPeptidyl-Dipeptidase AProtein Hydrolysatesangiotensin-I-converting enzyme inhibitory peptideantihypertensionLineweaver-Burk plotmolecular dockingpearl oyster

Identifiers

PMID31398788
PMCPMC6723713
OpenAlexW2967986987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.